top of page

PK/PD and Biodistribution for Cell Therapy

VMI-Trac™ enables non-invasive, longitudinal tracking of therapeutic cells by MRI, providing quantitative insight into biodistribution, localization, persistence and targeting.
 
Need an end-to-end PK/PD and biodistribution data package? Together with our established partner network, VisiCELL deliver the data your cell therapy program needs.

Start with VMI-Trac™

Build the data you need. Faster.

VisiCELL offers ready to deploy, end-to-end cell-tracking package designed to give your program a faster path to PK/PD and biodistribution data, without having to build the workflow from scratch. Designed to plug into your existing development program, the package helps reduce setup time and complexity so you can move more quickly from study planning to actionable data.

From labeling to data

Integrated capabilities

VisiCELL provides the core cell-tracking technology, including patented VMI-Trac™ labeling agents, optimized labeling and imaging protocols, and quantitative imaging analytics. When additional capabilities are needed, we work through an established network of imaging centers, core facilities, and study partners to help generate an integrated PK/PD and biodistribution data package without requiring you to build the imaging infrastructure or expertise internally.

The VisiCELL Advantage

See more. Decide with better data.

Adding quantitative cell tracking to your development program can help you:

  1. Generate decision-ready PK/PD and biodistribution insight into persistence, targeting, and therapeutic response

  2. Make faster go/no-go, dosing, and study-design

  3. Monitor therapeutic cells longitudinally by MRI, without radiation or biopsies

VMI-Trac™ provides the tracking technology. VisiCELL and our partners turn it into the PK/PD and biodistribution data your program needs.

bottom of page